Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the DEAD-Box RNA Helicase eIF4A with Rocaglates—A Pan-Antiviral Strategy for Minimizing the Impact of Future RNA Virus Pandemics
Gaspar Taroncher‐Oldenburg, Christin Müller, Wiebke Obermann, et al.
Microorganisms (2021) Vol. 9, Iss. 3, pp. 540-540
Open Access | Times Cited: 22

Showing 22 citing articles:

The RNA helicase DDX39A binds a conserved structure in chikungunya virus RNA to control infection
Iulia Tapescu, Frances Taschuk, Swechha M. Pokharel, et al.
Molecular Cell (2023) Vol. 83, Iss. 22, pp. 4174-4189.e7
Open Access | Times Cited: 16
MNK, mTOR or eIF4E-selecting the best anti-tumor target for blocking translation initiation
Shuo Li, Jia‐Shu Chen, Xiangqian Li, et al.
European Journal of Medicinal Chemistry (2023) Vol. 260, pp. 115781-115781
Closed Access | Times Cited: 7
Comparative phytochemistry of flavaglines (= rocaglamides), a group of highly bioactive flavolignans from Aglaia species (Meliaceae)
Harald Greger
Phytochemistry Reviews (2021) Vol. 21, Iss. 3, pp. 725-764
Open Access | Times Cited: 19
Comparing the Effects of Rocaglates on Energy Metabolism and Immune Modulation on Cells of the Human Immune System
Susanne Schiffmann, Marina Henke, Michelle Seifert, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5872-5872
Open Access | Times Cited: 6
MYC inhibitors in multiple myeloma
Sandra Martínez-Martín, Laura Soucek
Cancer Drug Resistance (2021)
Open Access | Times Cited: 16
Identification of structurally re-engineered rocaglates as inhibitors against hepatitis E virus replication
Dimas Praditya, Mara Klöhn, Yannick Brüggemann, et al.
Antiviral Research (2022) Vol. 204, pp. 105359-105359
Open Access | Times Cited: 11
Potent anti-coronaviral activity of pateamines and new insights into their mode of action
F. Magari, Henri Messner, Florian Salisch, et al.
Heliyon (2024) Vol. 10, Iss. 13, pp. e33409-e33409
Open Access | Times Cited: 1
Halogenated Rocaglate Derivatives: Pan-antiviral Agents against Hepatitis E Virus and Emerging Viruses
Catherine Victoria, Göran Schulz, Mara Klöhn, et al.
Journal of Medicinal Chemistry (2023) Vol. 67, Iss. 1, pp. 289-321
Open Access | Times Cited: 4
Rocaglates as Antivirals: Comparing the Effects on Viral Resistance, Anti-Coronaviral Activity, RNA-Clamping on eIF4A and Immune Cell Toxicity
Wiebke Obermann, Alexandra Friedrich, Ramakanth Madhugiri, et al.
Viruses (2022) Vol. 14, Iss. 3, pp. 519-519
Open Access | Times Cited: 8
In Vitro Safety, Off-Target and Bioavailability Profile of the Antiviral Compound Silvestrol
Susanne Schiffmann, Sandra Gunne, Thomas Ulshöfer, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 9, pp. 1086-1086
Open Access | Times Cited: 8
Broad anti-pathogen potential of DEAD box RNA helicase eIF4A-targeting rocaglates
Wiebke Obermann, Mohammad Farhan Darin Azri, Leonie Konopka, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
In vitro discovery of a therapeutic lead for HFMD from a library screen of rocaglates/aglains
Adrian Oo, Angel Borge, Regina Ching Hua Lee, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Exploiting Translation Machinery for Cancer Therapy: Translation Factors as Promising Targets
Urmila Sehrawat
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10835-10835
Open Access
Immune Modulatory Profile of the Pateamines PatA and Des-Methyl Des-Amino PatA
Susanne Schiffmann, Marina Henke, Sophie Brünner, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11430-11430
Open Access
Established and Emerging Roles of DEAD/H‐Box Helicases in Regulating Infection and Immunity
Mark R. Parthun, Matthew E. Long, Emily A. Hemann
Immunological Reviews (2024)
Open Access
Repurposing Drugs for Viruses and Cancer: A Novel Drug Repositioning Strategy for COVID-19
Ka Heng Wong, C. Lim, Ashley Jia Wen Yip, et al.
(2023), pp. 423-450
Closed Access | Times Cited: 1
Current understanding on molecular drug targets and emerging treatment strategy for novel coronavirus-19
Khadga Raj, Karamjeet Kaur, Ghanshyam Das Gupta, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2021) Vol. 394, Iss. 7, pp. 1383-1402
Open Access | Times Cited: 3
Molecular Dynamics Simulations Identify Tractable Lead-like Phenyl-Piperazine Scaffolds as eIF4A1 ATP-competitive Inhibitors
Derek J. Essegian, Tyler A. Cunningham, Christopher J. Zerio, et al.
ACS Omega (2021) Vol. 6, Iss. 38, pp. 24432-24443
Open Access | Times Cited: 3
Enzymatic and Molecular Characterization of Anti-Leishmania Molecules That Differently Target Leishmania and Mammalian eIF4A Proteins, LieIF4A and eIF4AMus
Yosser Zina Abdelkrim, Emna Harigua‐Souiai, Imen Bassoumi-Jamoussi, et al.
Molecules (2022) Vol. 27, Iss. 18, pp. 5890-5890
Open Access | Times Cited: 2
Electrical characterization of phytoplankton suspensions using impedance spectroscopy
Margaret R. Jett, Mohamed Z. Rashed, Susan P. Hendricks, et al.
Journal of Applied Phycology (2021) Vol. 33, Iss. 3, pp. 1643-1650
Closed Access | Times Cited: 2
In silico, biochemical, and in vitro analysis of silvestrol binding to the DEAD box RNA helicase eIF4A reveals broad anti-pathogen potential of rocaglates across the eukaryotic tree of life
Wiebke Obermann, Mohammad Farhan Darin Azri, Leonie Konopka, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Flavaglines: Their Discovery from Plants Used in Traditional Chinese Medicine, Synthesis, and Drug Development Against Cancer and Immune Disorders
Dong Wang, Mustafa A. Tezeren, Hussein Abou‐Hamdan, et al.
Current Chinese chemistry (2021) Vol. 2, Iss. 2
Open Access
Page 1

Scroll to top